期刊文献+

培门冬酶治疗急性淋巴细胞性白血病的护理 被引量:8

Nursing of Pegaspargase Therapy for Acute Lymphocytic Leukemia
下载PDF
导出
摘要 目的探讨培门冬酶治疗急性淋巴细胞性白血病的护理。方法以培门冬酶肌内注射治疗15例急性淋巴细胞性白血病患儿。结果出现2例过敏反应,4例肝功异常,8例凝血功能异常,1例低蛋白血症,9例可逆性骨髓抑制。结论应用培门冬酶发生不良反应的概率较高,护理上应做到细致周到的病情观察、及时有效的对症处理,以提高用药的安全性。 Objective To explore the nursing methods of pegaspargase therapy for acute lymphocytic leukemia.MethodsIntramuscular injection of pegaspargase was applied to treat 15 children with acute lymphocytic leukemia.ResultsAllergic reaction occurred in 2 children,hypohepatia in 4 children,abnormal function of cruor in 8 children,hypoproteinemia in 1 child,and reversible myelosuppression in 9 children.ConclusionThe incidence of adverse reactions of pegaspargase is comparatively higher.Intensive nursing observation combined with timely and valid allopathy plays a crucial role in improving the security of the medication.
出处 《解放军护理杂志》 2012年第16期48-50,共3页 Nursing Journal of Chinese People's Liberation Army
关键词 培门冬酶 淋巴细胞性白血病 护理 pegaspargase lymphocytic leukemia nursing
  • 相关文献

参考文献4

二级参考文献12

  • 1过毅.左旋门冬酰胺酶脱敏法治疗急性淋巴细胞白血病(附5例报告)[J].中华儿科杂志,2005,43(4):309-310. 被引量:5
  • 2张丽娜,宫道华.左旋门冬酰胺酶治疗小儿急性淋巴细胞性白血病的毒副反应[J].江苏医药,2005,31(5):392-393. 被引量:2
  • 3孙立荣,庞秀英,李学荣,卢愿,宋爱琴,仲任,赵艳霞.急性淋巴细胞性白血病门冬酰胺酶治疗期间凝血功能检测的必要性及干预治疗[J].临床儿科杂志,2006,24(11):930-932. 被引量:1
  • 4Albertsen BK, Schruder H, Ingerslev J,et al. Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system. Br J Haematol, 2001, 115:983-990.
  • 5Avramis VI, Sencer S, Periclou AP, et al. A randomized comparison of native Eseherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children' s Cancer Group study. Blood,2002, 99 : 1986-1994.
  • 6Koerholz D, Brueck M, Nuemberger W, et al. Chemical and immunological characteristics of four different L-asparaginase preparations. Eur J Haematol, 1989,42:417-424.
  • 7Hawkins DS, Park JR, Thomson BG, et al. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia. Clin Cancer Res, 2004, 10:5335-5341.
  • 8Graham ML. Pegaspargase: a review of clinical studies. Adv Drug Deliv Rev, 2003, 55:1293-1302.
  • 9Mauz-Korholz C, Junker R, Gobel U, et al. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli L-asparaginase. Thromb Haemost,2000, 83:840- 843.
  • 10Alvarez OA, Zimmerman G. Pegaspargase-induced pancreatitis. Med Pediatr Oncol, 2000, 34:200-205.

共引文献31

同被引文献40

引证文献8

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部